Stanford University School of Medicine
Stanford, California, 94305, United States
NCT Number: NCT00186576
To improve survival outcomes for patients with MDS and MPD with a nonmyeloablative allogeneic hematopoietic cell transplant.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
Stanford, California, 94305, United States
Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation for Treatment of Myelodysplastic Syndromes and Myeloproliferative Disorders (Except CML)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Myelodysplastic Syndromes
Time frame: 1 year
Time frame: 1 year
Stanford University
Other
Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation for Treatment of Myelodysplastic Syndromes and Myeloproliferative Disorders (Except CML)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00186342
Acute Disease, Blood and Marrow Transplant (BMT)
Stanford, California, United States
View Trial DetailsNCT02320656
Acute Leukemia, Bone Marrow Diseases
Marseille, France
View Trial DetailsNCT00305682
Bone Marrow Diseases, Hematologic Diseases
Minneapolis, Minnesota, United States
View Trial DetailsNCT00061581
Acute Lymphocytic Leukemia, Acute Myelocytic Leukemia
Bethesda, Maryland, United States
View Trial Details